Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cell Transplantation | 79 | 2024 | 5716 | 7.910 |
Why?
|
Anemia, Sickle Cell | 25 | 2024 | 1065 | 5.170 |
Why?
|
Graft vs Host Disease | 30 | 2024 | 3048 | 2.610 |
Why?
|
Fetal Hemoglobin | 9 | 2024 | 346 | 1.900 |
Why?
|
Transplantation Conditioning | 20 | 2024 | 1601 | 1.800 |
Why?
|
beta-Thalassemia | 5 | 2024 | 236 | 1.700 |
Why?
|
Homosexuality, Male | 13 | 2024 | 1344 | 1.660 |
Why?
|
Leukemia, Myeloid, Acute | 15 | 2024 | 3626 | 1.550 |
Why?
|
Sexual Partners | 7 | 2020 | 807 | 1.480 |
Why?
|
Transplantation, Homologous | 25 | 2024 | 4835 | 1.240 |
Why?
|
Hemophilia B | 2 | 2020 | 83 | 1.190 |
Why?
|
Heterocyclic Compounds | 4 | 2022 | 245 | 1.120 |
Why?
|
Hematopoietic Stem Cells | 10 | 2024 | 3408 | 1.090 |
Why?
|
Sexual Behavior | 7 | 2022 | 2200 | 0.980 |
Why?
|
Hemophilia A | 2 | 2020 | 359 | 0.970 |
Why?
|
Blood Component Removal | 2 | 2022 | 132 | 0.930 |
Why?
|
Hematologic Neoplasms | 8 | 2024 | 1907 | 0.910 |
Why?
|
HLA Antigens | 3 | 2024 | 1336 | 0.800 |
Why?
|
Stereotaxic Techniques | 1 | 2024 | 559 | 0.760 |
Why?
|
Transplants | 1 | 2023 | 209 | 0.720 |
Why?
|
Dyskeratosis Congenita | 1 | 2021 | 70 | 0.720 |
Why?
|
Isoantibodies | 1 | 2024 | 681 | 0.690 |
Why?
|
Electrodes, Implanted | 1 | 2024 | 841 | 0.660 |
Why?
|
Hepatitis, Autoimmune | 1 | 2021 | 173 | 0.640 |
Why?
|
Negotiating | 1 | 2020 | 152 | 0.610 |
Why?
|
HIV Infections | 13 | 2024 | 17589 | 0.610 |
Why?
|
Tetany | 1 | 2017 | 13 | 0.600 |
Why?
|
Gonorrhea | 1 | 2022 | 355 | 0.600 |
Why?
|
Splenectomy | 1 | 2019 | 392 | 0.590 |
Why?
|
Plasma Cells | 1 | 2021 | 599 | 0.590 |
Why?
|
Bone Marrow | 7 | 2023 | 2935 | 0.570 |
Why?
|
Sexually Transmitted Diseases | 2 | 2022 | 668 | 0.560 |
Why?
|
Tissue and Organ Harvesting | 1 | 2020 | 373 | 0.540 |
Why?
|
Self Care | 3 | 2019 | 801 | 0.540 |
Why?
|
Organ Preservation | 1 | 2020 | 394 | 0.530 |
Why?
|
Humans | 127 | 2024 | 768887 | 0.530 |
Why?
|
Immunocompromised Host | 1 | 2021 | 865 | 0.520 |
Why?
|
Hypocalcemia | 1 | 2017 | 205 | 0.520 |
Why?
|
Child | 41 | 2024 | 80969 | 0.510 |
Why?
|
Bone Marrow Transplantation | 3 | 2023 | 2709 | 0.500 |
Why?
|
Antigens, CD34 | 8 | 2024 | 656 | 0.500 |
Why?
|
Trust | 1 | 2020 | 532 | 0.480 |
Why?
|
Lung Transplantation | 2 | 2024 | 1309 | 0.470 |
Why?
|
Blood Transfusion | 2 | 2019 | 1309 | 0.460 |
Why?
|
Transplantation, Autologous | 5 | 2024 | 2126 | 0.460 |
Why?
|
Myelodysplastic Syndromes | 2 | 2021 | 1399 | 0.460 |
Why?
|
Erythrocytes | 1 | 2023 | 2421 | 0.450 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2024 | 1560 | 0.450 |
Why?
|
Neuroblastoma | 2 | 2023 | 1266 | 0.450 |
Why?
|
Physicians | 2 | 2024 | 4607 | 0.440 |
Why?
|
AIDS Serodiagnosis | 3 | 2020 | 220 | 0.430 |
Why?
|
Young Adult | 29 | 2024 | 60110 | 0.400 |
Why?
|
Adolescent | 31 | 2024 | 89247 | 0.380 |
Why?
|
Recurrence | 12 | 2024 | 8512 | 0.380 |
Why?
|
Tissue and Organ Procurement | 1 | 2020 | 986 | 0.380 |
Why?
|
Patient Preference | 1 | 2019 | 947 | 0.370 |
Why?
|
Myocardium | 1 | 2024 | 4790 | 0.370 |
Why?
|
Aviation | 1 | 2011 | 49 | 0.370 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 2 | 2023 | 263 | 0.350 |
Why?
|
Social Support | 2 | 2020 | 2193 | 0.350 |
Why?
|
Preventive Health Services | 1 | 2015 | 568 | 0.340 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1602 | 0.320 |
Why?
|
Hypoglycemia | 1 | 2016 | 895 | 0.320 |
Why?
|
gamma-Globins | 4 | 2024 | 105 | 0.310 |
Why?
|
Adult | 42 | 2024 | 223818 | 0.310 |
Why?
|
Statistics as Topic | 1 | 2015 | 2359 | 0.310 |
Why?
|
Mass Screening | 5 | 2020 | 5455 | 0.300 |
Why?
|
Electroencephalography | 1 | 2024 | 6318 | 0.300 |
Why?
|
Tissue Donors | 5 | 2024 | 2382 | 0.300 |
Why?
|
Survivors | 7 | 2024 | 2383 | 0.300 |
Why?
|
Laparoscopy | 1 | 2019 | 2055 | 0.290 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5520 | 0.280 |
Why?
|
Quality of Life | 7 | 2022 | 13510 | 0.280 |
Why?
|
Male | 45 | 2024 | 365249 | 0.270 |
Why?
|
Hematopoietic Stem Cell Mobilization | 3 | 2022 | 225 | 0.270 |
Why?
|
Benzylamines | 3 | 2022 | 251 | 0.270 |
Why?
|
Child, Preschool | 13 | 2024 | 42684 | 0.270 |
Why?
|
Heart Transplantation | 1 | 2020 | 3301 | 0.260 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9264 | 0.250 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7460 | 0.240 |
Why?
|
United States | 17 | 2024 | 73180 | 0.240 |
Why?
|
Biomedical Research | 1 | 2020 | 3463 | 0.230 |
Why?
|
Retrospective Studies | 21 | 2024 | 81892 | 0.230 |
Why?
|
Pneumocystis carinii | 1 | 2024 | 72 | 0.220 |
Why?
|
Hypoglycemic Agents | 1 | 2016 | 3110 | 0.220 |
Why?
|
Hemoglobin, Sickle | 1 | 2023 | 113 | 0.210 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2024 | 310 | 0.210 |
Why?
|
Hydroxyurea | 1 | 2024 | 284 | 0.210 |
Why?
|
Fiducial Markers | 1 | 2024 | 134 | 0.210 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2024 | 242 | 0.210 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1519 | 0.200 |
Why?
|
Histocompatibility Testing | 1 | 2024 | 716 | 0.200 |
Why?
|
Adrenoleukodystrophy | 1 | 2024 | 144 | 0.200 |
Why?
|
Leukapheresis | 1 | 2022 | 150 | 0.200 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2024 | 305 | 0.190 |
Why?
|
Cardiomyopathies | 2 | 2024 | 2057 | 0.190 |
Why?
|
Graft Survival | 3 | 2022 | 3888 | 0.190 |
Why?
|
Thrombotic Microangiopathies | 1 | 2022 | 124 | 0.180 |
Why?
|
Serologic Tests | 2 | 2020 | 383 | 0.180 |
Why?
|
beta-Globins | 1 | 2021 | 112 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2023 | 9442 | 0.180 |
Why?
|
Mycoses | 1 | 2023 | 386 | 0.170 |
Why?
|
Burkitt Lymphoma | 1 | 2022 | 338 | 0.170 |
Why?
|
Fibrosis | 2 | 2024 | 2081 | 0.170 |
Why?
|
Vascular System Injuries | 1 | 2023 | 248 | 0.170 |
Why?
|
Community Health Planning | 1 | 2020 | 164 | 0.170 |
Why?
|
Female | 31 | 2024 | 397464 | 0.170 |
Why?
|
Advisory Committees | 1 | 2024 | 797 | 0.170 |
Why?
|
Hematology | 1 | 2023 | 243 | 0.170 |
Why?
|
Neoplasms | 7 | 2024 | 22390 | 0.170 |
Why?
|
Acute Disease | 4 | 2024 | 7245 | 0.170 |
Why?
|
Emergency Medical Services | 1 | 2011 | 1947 | 0.160 |
Why?
|
Prognosis | 5 | 2024 | 30044 | 0.160 |
Why?
|
Telemedicine | 2 | 2020 | 3109 | 0.160 |
Why?
|
Cyclophosphamide | 5 | 2023 | 2227 | 0.160 |
Why?
|
Chromosome Deletion | 1 | 2024 | 1390 | 0.160 |
Why?
|
Mycophenolic Acid | 1 | 2021 | 348 | 0.160 |
Why?
|
Research Design | 1 | 2015 | 6213 | 0.160 |
Why?
|
Primary Graft Dysfunction | 1 | 2020 | 112 | 0.160 |
Why?
|
Reference Standards | 1 | 2022 | 1014 | 0.160 |
Why?
|
Infertility | 2 | 2024 | 654 | 0.160 |
Why?
|
Nucleotides | 1 | 2021 | 455 | 0.150 |
Why?
|
Disease-Free Survival | 4 | 2024 | 6856 | 0.150 |
Why?
|
Career Choice | 1 | 2024 | 769 | 0.140 |
Why?
|
Memory, Short-Term | 1 | 2024 | 1010 | 0.140 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 271 | 0.140 |
Why?
|
Promoter Regions, Genetic | 3 | 2024 | 5801 | 0.140 |
Why?
|
Myeloproliferative Disorders | 1 | 2023 | 616 | 0.140 |
Why?
|
Tacrolimus | 1 | 2021 | 750 | 0.140 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2021 | 792 | 0.140 |
Why?
|
Chromosome Aberrations | 1 | 2024 | 1780 | 0.140 |
Why?
|
Survival Rate | 3 | 2021 | 12873 | 0.140 |
Why?
|
Internet | 2 | 2024 | 3112 | 0.140 |
Why?
|
Fatty Liver | 1 | 2023 | 810 | 0.140 |
Why?
|
Unsafe Sex | 1 | 2018 | 239 | 0.140 |
Why?
|
Germ Cells | 1 | 2020 | 644 | 0.130 |
Why?
|
Repressor Proteins | 3 | 2024 | 2986 | 0.130 |
Why?
|
Lymphoma, B-Cell | 1 | 2022 | 945 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2024 | 2357 | 0.130 |
Why?
|
Survival Analysis | 3 | 2023 | 10115 | 0.130 |
Why?
|
Clinical Competence | 1 | 2011 | 4859 | 0.120 |
Why?
|
Adenine | 1 | 2021 | 995 | 0.120 |
Why?
|
Testicular Neoplasms | 1 | 2021 | 805 | 0.120 |
Why?
|
Hypogonadism | 1 | 2021 | 805 | 0.120 |
Why?
|
Infant | 7 | 2024 | 36541 | 0.120 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2211 | 0.120 |
Why?
|
Leukemia | 1 | 2023 | 1520 | 0.120 |
Why?
|
Interferon Type I | 1 | 2018 | 569 | 0.120 |
Why?
|
Central Nervous System Neoplasms | 1 | 2023 | 930 | 0.120 |
Why?
|
Antibodies | 1 | 2022 | 2422 | 0.120 |
Why?
|
Vaccines | 1 | 2023 | 842 | 0.110 |
Why?
|
Middle Aged | 17 | 2024 | 223740 | 0.110 |
Why?
|
Research Personnel | 1 | 2019 | 590 | 0.110 |
Why?
|
Heroin Dependence | 1 | 2015 | 173 | 0.110 |
Why?
|
Treatment Outcome | 9 | 2024 | 65485 | 0.110 |
Why?
|
Caregivers | 2 | 2023 | 2308 | 0.110 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 239 | 0.110 |
Why?
|
HIV Seropositivity | 1 | 2019 | 967 | 0.110 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2023 | 4053 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1119 | 0.110 |
Why?
|
Bisexuality | 1 | 2015 | 295 | 0.100 |
Why?
|
Informed Consent | 1 | 2019 | 1010 | 0.100 |
Why?
|
Busulfan | 2 | 2024 | 259 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3967 | 0.100 |
Why?
|
Hemoglobinopathies | 2 | 2024 | 101 | 0.100 |
Why?
|
Lung Diseases | 1 | 2022 | 1943 | 0.100 |
Why?
|
Leukemia, T-Cell | 1 | 2011 | 102 | 0.100 |
Why?
|
Prisoners | 1 | 2015 | 316 | 0.090 |
Why?
|
Remission Induction | 3 | 2022 | 2411 | 0.090 |
Why?
|
Chronic Disease | 5 | 2024 | 9384 | 0.090 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2011 | 117 | 0.090 |
Why?
|
Whole-Body Irradiation | 2 | 2022 | 435 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2336 | 0.090 |
Why?
|
Indoles | 1 | 2018 | 1836 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2163 | 0.090 |
Why?
|
Risk Factors | 7 | 2024 | 74971 | 0.090 |
Why?
|
Patient Participation | 1 | 2019 | 1448 | 0.080 |
Why?
|
Graft Rejection | 1 | 2022 | 4492 | 0.080 |
Why?
|
Poverty | 1 | 2021 | 2720 | 0.080 |
Why?
|
Antigens, CD19 | 2 | 2022 | 446 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2527 | 0.080 |
Why?
|
Epilepsy | 1 | 2024 | 3326 | 0.080 |
Why?
|
Health Behavior | 1 | 2020 | 2649 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4755 | 0.080 |
Why?
|
Genomics | 1 | 2024 | 5928 | 0.070 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2021 | 631 | 0.070 |
Why?
|
Risk | 1 | 2020 | 9621 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4363 | 0.070 |
Why?
|
Mice | 7 | 2023 | 82074 | 0.070 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 3047 | 0.070 |
Why?
|
Suicide, Attempted | 1 | 2016 | 1409 | 0.070 |
Why?
|
DNA | 1 | 2021 | 7214 | 0.070 |
Why?
|
Dendritic Cells | 2 | 2023 | 2748 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10641 | 0.070 |
Why?
|
Terminal Care | 1 | 2019 | 1772 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36861 | 0.070 |
Why?
|
Liver Diseases | 1 | 2015 | 1305 | 0.070 |
Why?
|
Georgia | 2 | 2018 | 186 | 0.070 |
Why?
|
Escherichia coli | 1 | 2018 | 4212 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12563 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15955 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11934 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26384 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10397 | 0.060 |
Why?
|
Communication | 1 | 2020 | 3908 | 0.060 |
Why?
|
Cohort Studies | 4 | 2022 | 41800 | 0.060 |
Why?
|
Decision Making | 1 | 2019 | 3952 | 0.060 |
Why?
|
Pentamidine | 1 | 2024 | 44 | 0.060 |
Why?
|
Cell Communication | 1 | 2011 | 1660 | 0.060 |
Why?
|
Calcium | 1 | 2017 | 5792 | 0.060 |
Why?
|
Antisickling Agents | 1 | 2024 | 72 | 0.060 |
Why?
|
Animals | 8 | 2024 | 169408 | 0.060 |
Why?
|
Graft vs Leukemia Effect | 1 | 2024 | 121 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 18454 | 0.060 |
Why?
|
Aged | 8 | 2024 | 171790 | 0.060 |
Why?
|
T-Lymphocytes | 3 | 2022 | 10276 | 0.060 |
Why?
|
Survival | 1 | 2024 | 160 | 0.050 |
Why?
|
Myeloablative Agonists | 1 | 2024 | 210 | 0.050 |
Why?
|
Interferon-gamma | 1 | 2011 | 3163 | 0.050 |
Why?
|
Complement Inactivating Agents | 1 | 2022 | 53 | 0.050 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5195 | 0.050 |
Why?
|
Incidence | 3 | 2024 | 21545 | 0.050 |
Why?
|
Diterpenes | 1 | 2022 | 170 | 0.050 |
Why?
|
Computer Simulation | 1 | 2015 | 6289 | 0.050 |
Why?
|
Base Pairing | 1 | 2021 | 139 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18366 | 0.050 |
Why?
|
North America | 1 | 2024 | 1290 | 0.040 |
Why?
|
Stomach | 1 | 2004 | 702 | 0.040 |
Why?
|
Donor Selection | 1 | 2022 | 240 | 0.040 |
Why?
|
Research Report | 1 | 2023 | 369 | 0.040 |
Why?
|
Fertility | 1 | 2024 | 770 | 0.040 |
Why?
|
Base Sequence | 2 | 2021 | 12430 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2024 | 640 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20776 | 0.040 |
Why?
|
Transgenes | 1 | 2022 | 1016 | 0.040 |
Why?
|
Bacterial Translocation | 1 | 2018 | 74 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13699 | 0.040 |
Why?
|
Genome, Human | 2 | 2021 | 4456 | 0.040 |
Why?
|
Lymphocyte Depletion | 1 | 2019 | 605 | 0.040 |
Why?
|
Siblings | 1 | 2022 | 829 | 0.040 |
Why?
|
Safe Sex | 1 | 2018 | 144 | 0.040 |
Why?
|
Bacteremia | 1 | 2024 | 985 | 0.040 |
Why?
|
Cause of Death | 2 | 2021 | 3721 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 621 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3441 | 0.030 |
Why?
|
Mutagenesis | 1 | 2021 | 1229 | 0.030 |
Why?
|
Pain | 2 | 2022 | 5100 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2023 | 1476 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2024 | 7860 | 0.030 |
Why?
|
Bacterial Infections | 1 | 2024 | 1397 | 0.030 |
Why?
|
Gene Targeting | 1 | 2019 | 841 | 0.030 |
Why?
|
Point Mutation | 1 | 2021 | 1595 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2021 | 1019 | 0.030 |
Why?
|
Erythropoiesis | 1 | 2019 | 693 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2024 | 1672 | 0.030 |
Why?
|
Disease Progression | 2 | 2023 | 13677 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2019 | 1498 | 0.030 |
Why?
|
Fetal Blood | 1 | 2022 | 1360 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1866 | 0.030 |
Why?
|
Risk-Taking | 1 | 2020 | 1025 | 0.030 |
Why?
|
Gender Identity | 1 | 2020 | 770 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 790 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2871 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1962 | 0.030 |
Why?
|
Sulfonamides | 1 | 2022 | 1982 | 0.030 |
Why?
|
Cost of Illness | 1 | 2022 | 1959 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2023 | 2682 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2021 | 1597 | 0.020 |
Why?
|
Mice, Congenic | 1 | 2011 | 98 | 0.020 |
Why?
|
Transplantation, Isogeneic | 1 | 2011 | 249 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 16051 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2019 | 1438 | 0.020 |
Why?
|
Receptors, Interferon | 1 | 2011 | 115 | 0.020 |
Why?
|
RNA | 1 | 2021 | 2727 | 0.020 |
Why?
|
Critical Care | 1 | 2024 | 2715 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4273 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3436 | 0.020 |
Why?
|
Prospective Studies | 1 | 2015 | 54950 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2018 | 14485 | 0.020 |
Why?
|
Models, Immunological | 1 | 2011 | 518 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2021 | 1946 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5323 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4651 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39394 | 0.020 |
Why?
|
Genotype | 1 | 2023 | 13048 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 24330 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5803 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3538 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9549 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3836 | 0.020 |
Why?
|
Medicaid | 1 | 2021 | 2843 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2680 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15603 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1169 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22294 | 0.020 |
Why?
|
Lung | 1 | 2024 | 10097 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 8095 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14795 | 0.010 |
Why?
|
Pilot Projects | 1 | 2018 | 8742 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 13054 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7453 | 0.010 |
Why?
|
Models, Biological | 1 | 2019 | 9499 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12174 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2011 | 5505 | 0.010 |
Why?
|
Necrosis | 1 | 2004 | 1621 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 13087 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9564 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2011 | 3116 | 0.010 |
Why?
|
Brain | 1 | 2024 | 27476 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59738 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30266 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 22381 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2004 | 26394 | 0.000 |
Why?
|